TP53 and breast carcinoma: Furthermore, p53-mt breast cancer cells (BT-549, MDA-MB-231, MDA-MB-468, and HCC70) were more sensitive to BCar treatment compared to p53-wt breast cancer cells (MDA-MB-175-VII and MDA-MB-361) (Fig. 2 and Table 1).